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H-2 antigens are expressed in substantial amounts on murine blood platelets (for H-2 antigenic 
content 1 lymphocyte - 50 platelets) whereas Ia antigens are probably not expressed at all 
(minimal Ia antigenic content more than 35 times lower than for H-2). This property of blood 
platelets makes themvery useful for the selective absorption of anti-H-2 antibodies from complex 
sera and for the preparation of specific anti-Ia antibodies from such sera. In 20 sera produced 
against the complete H-2 complex, 12 sera contained anti-Ia antibodies beside the expected 
anti-H-2 antibodies. In two sera, separation of the anti-Ia antibodies was easily obtained by 
absorption of the anti-H-2 antibodies on platelets. The analysis of one serum (C3H.Q x B10.D2) 
anti-C3H [(q x d) anti-k] showed that, in addition to the expected anti-H-2.23 ~ n ( 1  anti-Ia.2 
antibodies, it contained at least three other Ia antibodies, separable by absorption on 
lymphocytes, which recognized three antigens-Ia. 17, determined by the haplotypes k ,  f ,  s ,  t ,  1; 
Ia.18, determined by the haplotypes k, f, s; and Ia. 19 determined by the haplotypes k and r. The  
genes are located in the I-A and/or I-B subregions of the H-2  complex. 
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l a  (I-region associated) antigens are a new located in the H-2 complex at the I region, 
class of alloantigens on the membranes of which was initially defined by immune 
murine cells (David et al. 1973, Hauptfeld et response ( I T )  genes (Benacerraf & McDevitt 
al. 1973, Sachs 8~ Cone 1973, Hammerling 1972). The I region is divided into at least 
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be considered as being composed of six 
regions or sub-regions, K, I-A, I-B, I-C, S, 
D* (for review, see Shreffler & David 1975, 
Sachs et al. 1975). Originally anti I-a sera 
were induced through immunisation be- 
tween strains carrying recombinant hap- 
lotypes such that donor and recipient shared 
in common all the genes of the H-2complex 
except those of the Z region (David et al. 
1973, Hauptfeld et al. 1973). It is now 
apparent that many immune sera induced 
against the products of the whole H-2 hap- 
lotype contain both anti-H-2 (K and/or D) 
and anti-Ia antibodies (Shreffler & David 
1975, Sachs & Cone 1975). When strains 
carrying the appropriate recombinant hap- 
lotypes are available, their lymphocytes can 
be used for selective absorption of anti-H-2 
antibodies. On the other hand, the different 
tissue distribution of H-2 and Ia antigens 
should also permit the absorption of anti- 
H-2 antibodies. Contrary to H-2 antigens 
which are expressed on almost all tissues 
(Snell & Stimpfling 19641, la antigens are 
detected only on certain cells- essentially B 
lymphocytes, macrophages, epidermal cells 
and sperm cells (Shreffler & David 1975, 
McDevitt et al. 1974, Hauptfeld et al. 1974, 
Unanue et al. 1974). They are also 
expressed on thymocytes but probably more 
weakly and/or only on a subpopulation of 
these cells (Shreffler & David 1975, Fre- 
*The “haplotype composition” of a given strain 
when mentioned in this report refers to the genes 
of the H-2 complex at the six regions or subre- 
gions listed in the order, K ,  I-A, I-B, I-C. S ,  D. 
The nomenclature for the H-2 complex and the 
Ia antigens will be as recently proposed (Klein et 
a]. 1974, Shreffler et al. 1974). Whenever possible 
without ambiguity the H-2 haplotype will be 
designated by the italicized superscript symbol 
printed on line with the text (e.g. k for H-Zk). 
Abbreviations used in this paper: LCT: dye 
exclusion lymphocytotoxicity technique; LyCF: 
spleen lymphocyte complement fixation techni- 
que; PICF: pIatelet Complement fixation 
technique. 
linger et al. 1974a). Ia antigens are not 
detected on erythrocytes, o r  on kidney, liver 
and brain tissues (Shreffler & David 1975, 
McDevitt et al. 1974). Erythrocytes and T 
cell tumors have already been used for the 
selective absorption of anti-H-2 antibodies 
(Davies & Hess 1974, Sachs &Cone 1975). It 
will be shown in this report that blood 
platelets can be very effective for this 
absorption. 
We have already shown (Colombani et al. 
1975) by a direct platelet complement fixa- 
tion test (PICF) and by absorption-elution 
analyses that platelets carry a substantial 
number of H-2 antigens without detectable 
Ia antigens. For that reason sera reacting 
with the lymphocytes, but not with the 
platelets, of a given strain are very likely to 
contain anti-Ia antibodies. Such a study has 
been done on 20 immune sera, 12 of which 
were shown to contain well-defined anti-Ia 
antibodies in addition to anti-H-2 
antibodies. A detailed study of one of these 
sera showed that the separation of anti-H-2 
and anti-Ia antibodies can be easily obtained. 
Another serum developed against the pro- 
ducts of the H-2k haplotype defined three 
new Ia specificities which will be described. 
Materials and Methods 
Animals and reagents: Inbred mouse strains 
and FI hybrids used in this study were all 
derived from the colony maintained in the 
Department of Human Genetics, University 
of Michigan. Immune sera were produced 
as previously described (Shreffler et al. 
1966). 
Preparation of cells: Spleen lymphocytes used 
for absorption or lymphocyte complement 
fixation (LyCF) were purified by flotation on 
Ficoll-Sodium metrizoate solution (Thorsby 
& Bratlie 1970), then washed and suspended 
in saline containing 0.1% NaNs and 0.1% 
bovine serum albumin, at the concentration 
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of 20,000 cells/Pl. Lymph node lymphocytes 
were prepared without flotation. The lym- 
phocytes used for absorption were a mixture 
of lymph node and spleen lymphocytes 
approximately in equal numbers. They were 
used less than 24 h after preparation. 
Blood platelets were obtained by differ- 
ential centrifugation from peripheral blood. 
The  bleeding was made from the retro- 
orbital sinus and the blood immediately 
mixed in a plastic tube with saline containing 
5% Na:, EDTA in the proportion of 4 vol of 
blood for 1 vol of anticoagulant solution. 
The platelets were then sedimented by cen- 
trifugation (1,600 g/20 min/4"C) and washed 
three times in saline. They were finally 
suspended in saline containing 0.1% NaN3 
at the concentration of 4 x 106/pl and kept at 
+4"C until used. They could be kept u p  to 
one month without any appreciable change 
in antigenic activity. The yield of platelet 
preparations was 0.95 5 0.15 x lo9 per ml of 
blood for 53 preparations made in 18 dif- 
ferentstrains.The suspensions contained less 
than 1 leucocyte/1,000 platelets. The same 
platelet suspensions were used for absorp- 
tion and PlCF. 
Serological tests: Dye exclusion LCT (David et 
al. 1973, Frelinger et al. 1974a), LyCF and 
PlCF (Colombani et al. 1975) microtech- 
niques were performed as previously 
described. In all cases unabsorbed rabbit 
serum was used as the source of comple- 
ment. 
Absorption-elution: Absorptions were made 
by incubation for 30 minor 1 h at 37°C of an  
appropriate dilution of immune serum with 
an appropriate number of platelets or lyrn- 
phocytes. After sensitization the cells were 
washed and elution performed in a small 
volume of saline acidified (pH 3.0) with HCl 
0.1N. After 20 min at room temperature the 
suspension was centrifuged and the super- 
natant decanted and neutralized (pH 7.0) 
with NaOH 0.04 N (Schulman et al. 1964). 
Results ' 
Screening for sera containing anti-Ia antibodies; 
Twenty immune sera were produced by 
immunization against strains carrying the 
H-2 haplotypes b, d, f, k,  p ,  9, r, s (nos. 1-20 in 
Table 1 ) .  In 15 cases the donor-recipient 
combination allowed immunization against 
products of the whole H-Zcomplex. In four 
cases immunization against the products of 
the H-2D region was "blocked" by the pre- 
sence of an allele shared in common by 
donor and recipient. In one case (serum no. 
6), immunization against the products of the 
H-ZK, I-A and I-B regions was similarly 
blocked. 
The  reactivity of the sera was studied 
against a panel of 15 strains carrying nine 
independent H-2 haplotypes (b, d, f, j ,  k ,  p ,  9, 
r, s) and six recombinant haplotypes (tl, y l ,  
h4, a, i5, t4) (see list of the strains in Table 2), 
by the LCT, LyCF and PlCF techniques. 
Essentially two patterns of reactivity were 
observed-the H-2 pattern, LCT(+) with 
100% of lymphocyte killing, LyCF(+), 
PlCF(+)-and the Ia-pattern, LCT(+) with a 
maximum lymphocyte killing less than 75%, 
LyCF(+), PlCF(-). The  H-2 pattern was 
observed against the immunizing strain, o r  
the strains carrying at the H-2K and/or D 
regions the same genes as the immunizing 
strain. The  Ia pattern was observed in 
strains with recombinant haplotypes when 
the target strain shared part of all of the I 
region with the immunizing strain. In addi- 
tion, a number of cross-reactions of both 
anti-H-2 and anti-Ia antibodies were 
observed, as expected from the H-2 (Dem- 
ant 1973) and Ia (Shreffler & David 1975, 
Sachs et al. 1975) charts. 
All sera contained the anti-H-2K and/or D 
antibodies expected from the immunization 
Combination (Table 1). T w o  sera contained 
only anti-H-2 antibodies (nos. 5 and 6). 
Twelve sera contained, in addition, well 
characterized anti-la antibodies-Ia.2 (no. 
7), Ia.1, 2, 3 (nos. 8 and 9), Ia.8 (no. 3). Ia.9 
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* indicates the presence of additional Ia specificities. 
(no.l), Ia.12 (nos. 15, 18 and 19), Ia.13 (nos. 
1 1 ,  12, 13 and 14). In certain cases (sera 
nos. 7 ,  8 and 9 for instance) extra reactions 
with an la pattern were observed. Six sera 
(nos. 2, 4, 10, 16, 17 and 20) contained, 
apart from the expected anti-H-2 
antibodies, weak cytotoxic antibodies (low 
titre and low percentage of killing) not yet 
identified. Out of the 20 sera screened, 
three were selected for further study:-no. 6 
( b  x a)  anti-k, (anti-H-2.32) as an example of 
immune serum containing only anti-H-2 
antibodies; no. 14 ( m  x b) anti-9, (anti- 
H-2.17 + Ia.13) as an example of anti-H-2 - 
Ia serum; and no. 7 ( q  x d) anti-k (anti- 
H-2.23 + Ia.2, . . .) for the study of the new 
anti-Ia antibodies it contained. Another 
serum not among the 20 sera was also used, 
no. 21 (9 x d)  anti-yl similar to no. 7 but for 
the absence of anti-H-2 antibodies, the 
H-2K and D regions being blocked by the 
immunization combination. 
Quantitative absorption of anti-H-2 and anti-la 
antibodies with lymphocytes and platelets: This 
experiment was carried out in order to 
evaluate the number of cells needed to 
absorb each type of antibody from two 
immune sera with about the same titre (Fig. 
1). A parallel absorption of the anti-H-2.32 
serum was observed with lymphocytes and 
platelets. A significant decrease in titre was 
induced by 1-2 x lo6 lymphocytes and 1-2 x 
10' platelets. A complete absorption was 
obtained with 16 x lo6 lymphocytes, and 
almost complete with 16 x 10' platelets. In 
this particular experiment the H-2 antigenic 
content of one lymphocyte was thus about 
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the same as that of 100 platelets. The 
specificity of the absorption was shown by 
the fact that no decrease of titre was induced 
by incubation with large numbers (64 x lo6 
lymphocytes or 40 x lo8 platelets) of H-2.32 
negative cells (B1O.A (4R)). BIO.K lympho- 
cytes absorbed both anti-H-2 and anti-Ia 
antibodies in about the same way. A signifi- 
cant absorption of the anti-Ia.2 antibody was 
obtained with 2 x lo6 lymphocytes and an 
almost complete absorption with 16 x lo6 
lymphocytes. On the other hand, no 
decrease of titre was observed even with 70 x 
10' platelets. As 2 x 10' platelets absorbed an 
anti-H-2 antibody when 70 x lo* platelets 
failed to absorb an anti-Ia antibody, it was 
possible to conclude that the Ia antigenic 
content of platelets was more than 70:2 = 
35 times lower than their H-2 antigenic 
content. 
Separation of anti-H-2.17 from anti-la. 1 3  in 
serum no. 14 - (m x b) anti-q (Fig. 2): When 
tested against the panel this serum reacted 
with an H-2 pattern against C3H.Q (H-2g) 
and with an Ia pattern against BIO.M (H-2') 
and BIO.P (H-2P). The last two strains are 
Ia.lJ(+). The serum thus contained both 
anti-H-2.17 and anti-Ia. 13 antibodies. In 
addition, it reacted against BlO.T(GR) 
(H--2y2, H-2.17(+) Ia.13(+)) and AQR 
(H-ZY', H-2.17(+) Ia.13(-)) with an H-2 
pattern. These two strains, together with 
BIO.M (H-2.17(-) Ia.13(+)), were used to 
dissociate the reactivities due to the two 
antibodies. Lymphocytes and platelets from 
the three strains were used for absorption- 
elution analyses. The reactivity of the unab- 
sorbed serum (curve a in Fig. 2) against 
AQR and BIO.M respectively showed that 
the anti-H-2.17 titre was much higher than 
ANTI-H2.32 (bxa)  anti-k ANTI-la. 1.2 (+H-2.23) ( q x d l  anti-k 
(C3H.Q xBI0.02) ANTI-C3H-AQR TARGET (BIOX A) ANTI-BIO.BR-B1O.K TARGET 
X - - - X - J 6 - - 4  
CC 1:640 
5 a ISO 
1 1 1 1 1 1 1 1 ~  I I I l l l l 1  
25050 I 2 4 8 16 32 64 I 2  4 8 163264128  
NUMBER OF LYMPHOCYTES (XI@) OR PLATELETS (x loa)  USED FOR ABSORPTION 
Figure 1. Quantitative absorption of anti-H-2 and anti-la antibodies with 
lymphocytes and blood platelets. 50,UL of immune serum diluted 1 : l O  was 
absorbed with the indicated numbers of B1O.K lymphocytes (o) ,  BIO.K 
platelets (X), BlO.A(4R) lymphocytes (0) or BlO.A(4R) platelets (+). After 
absorption the titer of the residual antibody was determined with the dye 
exclusion lymphocytotoxicity test. Each point represents the residual titer. On 
the left hand panel is shown reactivity of an anti-H-2 serum (#6) [(BIO X A) 
anti-B10.BR; (b x a) anti-k] against BI0.K target lymphocytes. On the right 
hand panel is shown reactivity of an Ia.2(+ H-2.23) serum (#7)  l(C3H.Q X 
B10.D2) anti-CSH; (q x d )  anti-k]. Since AQR target lymphocytes were used 
with this serum, only the anti-la antibodies reacted against the target. 
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Reagents BIO.T(GR) AQR 
the anti-Ia.13 titre. Absorption on (6R) lym- 
phocytes (curve b) removed both anti-H-2 
and anti-la antibodies. Eluate from (6R) 
lymphocytes (curve c) contained both 
activities. Absorption on (6R) platelets 
(curve d), AQR platelets (curve h) and lym- 
phocytes (curve f )  removed only anti-H-2 
antibody, and the corresponding eluates 
(curves e, i, g) contained only anti-H-2 
antibody. B1O.M lymphocytes absorbed 
BI0 .M 
(curve j) and released (curve k) anti-Ia 
antibody. BI0 .M platelets had no activity in 
absorption (curve 1) or elution (curve m). 
Apart from the LCT tests shown in Fig. 2, 
LyCF and PlCF tests were also done with all 
reagents. Perfectly consistent results were 
obtained. All reagents expected to contain 
only anti-H-2 antibodies (e, g, i, j )  reacted 
only with (6R) and AQR lymphocytes and 
platelets. Reagents expected to contain only 
BI0.T (6R)  TARGET 
qqqqq d H-2.17+ la. 13 
AUR TARGET 
qkkddd ti-2.17 
B I 0 . M  TARGET 
f f f f f f  Ia.13 
The immunization combination being (m X b) anti-q = __ ~~~~~ anti-qqqqq, 
the use of the three indicated targets made it possible to dissociate the reactivity 
of the two antibodies, anti-H-2.17 and anti-Ia. 13. The haplotype compositions 
for the target strains and for the immunization combination are listed in the 
order K ,  I-A, I-B, I-C:. S ,  D. 
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? + Ia . l?  
? 
(H-2.23) Ia.2 + Ia. l? 
? 
? 
Ia.2 + Ia.l? 
Ia.2 + la.]? 
(H-2.23) Ia.2 + Ia. l? 
(H-2.23) Ia.2 + Ia.l? 
? 
? 
#7 (C3H.Q x B10.D2) anti-C3H = anti-H-2.23 + Ial(?),  Ia.2 - ?; #21 (C3H.Q x B10.D2) anti-AQR = 
anti-Ia.l(?), Ia.2 - ?: # 7  absorbed, 250/Ll,diluted 1:lO were absorbed on 8 x lo9 BIO.K platelets. 
For recombinant haplotypes, the haplotype composition is indicated for the six regions or subregions of the H-2 
complex in the order: K, 1-A, I-B, I-C, S,  D. 
LCT-Dye exclusion lymphocytotoxicity, LyCF-spleen lymphocyte complement fixation, PlCF-platelets 
complement fixation. Numbers indicate reciprocals of titers. Numbers in brackets indicate highest percentage of 
killing in LCT. - indicates negative at 1 : l O  dilution. n.d. indicates not done. 
H-2.23 is relevant only to the reactivity of serum #7  unabsorbed. 
Ia antibodies (d, f ,  h, k )  reacted only with 
(6R) and BIO.M lymphocytes. Reagents sup- 
posed to contain both anti-H-2 and anti-Ia 
antibodies (a, c, 1) reacted with (6R) and 
AQR lymphocytes and platelets and with 
B1O.M lymphocytes. Reagents b and m sup- 
posed to contain no antibodies were non- 
reactive. 
Absorption-elution analysis of a complex serum 
no. 7 (q x d) anti-k: Out of the 20 sera studied 
this particular serum showed a number of 
extra reactions against the panel (Table 2). 
The expected antibodies in this immune 
serum were anti-H-2.23 and anti-Ia.1, 2. 
Apart from the expected reactions against 
the strains carrying the H-2 haplotypes k ,  t l ,  
SEPARATION OF ANTI-IA FROM ANTI-H-2 ANTIBODIES 81 
y l ,  h4, a, f, unexpected reactions were 
observed against the strains carrying the 
H-2 haplotypes j ,  r, s, t3, t4, i3, i5. All these 
latter reactions followed the Ia pattern and 
were not altered by absorption with BIO.K 
platelets. In addition, serum no. 21 ( q  x d) 
anti-yl which could contain only anti-Ia 
antibodies, reacted identically with serum 
no. 7 absorbed on BIO.K platelets or with 
the unabsorbed serum (except for an l a  
pattern of reaction instead of the H-2 pat- 
tern against BlO.K, BIO.A and BlO.A(4R)). 
An absorption-elution experiment using 
the lymphocytes of the strongly reacting 
strains was carried out in order to analyse 
these Ia reactions (Table 3). In every case 
the absorption was adequate since it 
removed all reactivity against the absorbing 
cells. B 10.K lymphocytes carrying the 
immunizing haplotype cleared all reactivity. 
On the other hand, all the other cells tested 
failed to absorb the anti-H-2.23 antibody 
reacting with BIO.K lymphocytes and in 
addition left unabsorbed one or more anti- 
Ia antibodies (including anti-Ia.2) reacting 
with AQR lymphocytes. The  absorption by 
B1O.S lymphocytes of the reactivity against 
BI0.M target cells (Ia. 1(+)) suggested that 
serum no. 7 did not contain the expected 
anti-Ia. 1 antibody since B 1O.S is Ia. 1 (-). In  
addition, B1O.S cannot possess any la anti- 
gen cross-reacting with Ia.1 since the origi- 
nal anti-Ia.1 antibody was made in a reci- 
pient strain carrying the same s genes as 
B1O.S at the Z region (David et al. 1973). 
The results of absorption could be 
explained by three specificities X, Y and 2 ,  
distributed as indicated in Table 3 (in addi- 
tion to Ia.2). BIO.M and B1O.S behaved 
identically (cross-absorption); this showed 
that both strains carry the same specificities 
(X and Y ) .  Specificity X is present on all the 
cells used for absorption; and is the only one 
carried by B 1 O.WB since all cells cleared the 
reactivity against B 10.WB lymphocytes. On 
the other hand, as absorption on B1O.WB 
lymphocytes left some reactivity against the 
other cells, other specificities were involved. 
At least two distinct specificities (Y and Z) 
were needed since there was no cross- 
absorption between B1O.RIII (Z) on the 
one hand and B1O.M or B1O.S ( Y )  on the 
other. All eluates were reactive against all 
targets in agreement with the hypothesis of 
one specificity (X) shared in common by all 
strains used for absorption. 
An unexpected result was the reactivity 
remaining against B 1O.S (9R) lymphocytes 
after absorption on B1O.S and BIO.M lym- 
phocytes. It was finally removed by a higher 
number of B1O.S lymphocytes. But even 
then B1O.M lymphocytes were ineffective. 
These results could be compared to the 
weak reactivity of sera nos. 7 and 2 1 against 
B 1 O.A(3R) and B lO.A(5R) (Table 2) and will 
be discussed later. 
Discussion 
The presence of H-2 antigens on blood 
platelets has already been reported 
(Schanzer et al. 1974) and their H-2 
antigenic content evaluated (1 lymphocyte - 30 platelets) (Colombani et al. 1975). The  
present evaluation (1 lymphocyte - 100 
platelets) was somewhat lower. Such varia- 
tions are likely to be due to experimental 
conditions, to the properties and perhaps 
the specificity of the antibody used for 
quantitative absorption. The  best average 
estimate could then be 1 lymphocyte - 50 
platelets. Ia antigens were not detectable on 
platelets, and their maximum amount esti- 
mated was less than 1:35 relative to the H-2 
antigenic content, which protably reflects a 
complete absence of Ia antigens. These 
results are in agreement with the ubiquitous 
distribution of H-2 antigens, and the 
restricted distribution of la antigens. 
The description of Ia antigens depends o n  
the production of appropriate antisera. 
Specific anti-Ia antibodies can be induced in 
donor-recipient combinations where 
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Immune sera 
and eluates 
immunization against H-2K and H-2L) pro- 
ducts is blocked, as was the case for serum 
no. 21. That is possible only when strains 
carrying the appropriate recombinant hap- 
lotypes are available. Another approach is to 
absorb the anti-H-2 antibodies from 
immune sera directed against the products 
of the whole H-2 complex. Erythrocytes 
(Davies & Hess 1974) and T cell tumours 
(Sachs & Cone 1975) have already been used 
for that purpose. The present results show 
that blood platelets are very effective for 
such absorptions because of their relatively 
Target strains" 
. 
B1O.K AQR Bl0.M BI0.S B1O.RIII B10.WB BlO.S(9R) 
k yl-qkkddd f S r j t4-ss~ddd 
high H-2 antigenic content in a small vol- 
ume. They can be obtained from any strain. 
Another advantage is the stability of H-2 
antigens on platelets (more than one month 
at t4"C). The  efficiency of the absorption 
was shown by the complete separation of 
anti-H-2.17 from anti-Ia.13 in a complex 
serum. This experiment was especially sig- 
nificant because in this particular serum the 
anti-H-2 antibody titre was much higher 
(1:2560) than the anti-Ia antibody titre 
(1:160). Such an absorption was even easier 
in the reverse situation, for example in 
# 7 Unabsorbed 128@( 640(77) 
# 7 Absorbed' on  lymphocjtes f r o m  
B1O.K - - 
640(100) 160(75) B1O.M 
B1O.S 640(100) 320(77) 
B1O.RIII 640( 100) 320(83) 
B1O.WB 640(100) 640(80) 
B1O.K 640( 100) 320(68) 
80(70) 80(71) 
SO(65) 80(59) B1O.M 
B 10.S 80(67) 80(69) 
BlO.RII1 320(85) 320(79) 
B1O.WB 160(70) 160(66) 
320(100) - AQR 
Eluate4  f r o m  sensitized lymphocytes f r o m  
AQR 










































SO(46) 160(7 1) 
80(57) 160(52) 
x X Y - ?  
For each strain the H-2 haplotype is indicated. The haplotype compositions for the recombinant 
haplotypes are given in the order: K ,  I -A ,  I-B, I-C, S ,  D. 
Numbers indicate reciprocals of titers. Numbers in brackets indicate highest percentage of killing. - 
indicates negative at 1:lO dilution, n.d. indicates not done. 
250pL of serum diluted 1:lO were absorbed on 1 x 10' lymphocytes. 
Reactivity after the standard absorption. 
Reactivity after absorption using three times more lymphocytes. 
' For acid elution 1 x los lymphocytes were sensitized with 100pLof undilutedserum. After washing, 
the elution was made in a volume of 50pL.  All sera and eluates were tested against C3H.Q 
lymphocytes with negative results. 
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serum no. 7 in which the anti-H-2 antibody 
titre was 1:320 (after absorption on AQR 
lymphocytes, Table 3) while the anti-Ia titre 
was l:G40-1:1280 (after absorption on 
BIO.K platelets, Table 2). These experi- 
ments showed also that anti-H-2 and anti-la 
antibodies could be easily eluted from their 
antigens at low pH. 
As shown by the study of 20 immune sera 
essentially developed against the products of 
the whole H-2 complex, the association of 
anti-Ia to anti-H-2 antibodies is very fre- 
quent. More than half of the sera contained 
both kinds of antibodies. This observation 
together with the possibility of selective 
absorption of anti-H-2 antibodies on 
platelets from the immunizing slrain, sug- 
gests that this approach will be useful for the 
description of new Ia specificities, particu- 
larly for the study of Ia antigens determined 
by haplotypes for which no recombinants 
are presently available. 
It is already apparent that a large number 
of distinct Ia specificities are determined at 
the three (or more) loci of the I region 
-I-A, I-B, I-C (Shreffler & David 1975, 
Sachs et al. 1975). Analyses of two anti-H-2’ 
sera (nos. 7 and 21) made possible the 
description of three new Ia specificities. 
They are distinct from the specificities 
already described as determined by the 
H-2’ haplotype (Ia.1, 2, 3, 7) on the basis of 
their strain distributions, and because, of 
these specificities, serum no. 7 could contain 
antibody only to Ia.2, since immunization 
against Ia.3 and 7 was blocked by the reci- 
pient combination. Absence of anti-Ia. 1 was 
shown by absorption analysis. These new Ia 
specificities are indeed determined at the I 
region and most likely by the I-A and/or I-B 
subregion as shown by the reactivity of 
serum DO. 7 against AQR lymphocytes and 
of serum no. 21 against the panel. In both 
cases the antibodies could be directed only 
against the products of k genes at the I-A 
and/or I-B loci; in addition, the identical 
reactivities of the two sera suggested that 
they contained the same anti-Ia antibodies. 
Finally, the fact that BIO.K platelets failed to 
absorb these antibodies confirmed that the 
antigens recognized are not H-2K or H-2D 
products. 
The  results of absorption with the reactive 
lymphocytes (Table 3) showed that three 
different specificities were involved, X 
(which w e  propose to call Ia.17) determined 
by H-2 haplotypes k, f, s, r, j, Y (Ia.18) 
determined by haplotypes k ,  f, s, Z (Ia.19 
determined by haplotypes k and r. 
A recent study (Gotze 1975) of a serum 
(DBAA x B10.D2) anti-AQR [ ( q x  d) anti-yl)] 
showed that it reacted with Ia antigens 
expressed on B and T cells from H-2‘ 
strains. Absorption studies indicated that B 
cells possess at least two Ia antigens, one 
being shared with T cells. This serum was 
essentially similar to serum no. 21. 
Even with these new specificities certain 
facts remained unexplained-the difficulty 
in absorbing out the reactivity of serum no. 7 
against BlOS(9R) lymphocytes with B1O.S 
and BIO.M lymphocytes, and the weak reac- 
tivity of both no. 7 and no. 21 sera against 
BlO.A(JR) and BlO.A(5R) lymphocytes. 
Some of these reactions might have been 
attributed to an anti-Tla.1, 3 antibody 
which could have been produced in both 
sera (Frelinger et al. 1974b)-(q, Tla”  x d, 
Tla‘) anti-k or anti-y1, both Tlu”; 
BIO.S(SR), BIO.A(5R) are T l a a  (BlO.A(SR) 
is also very likely T l u ” ) .  However, both sera 
were non-reactive against B 1 O.A(GR) which 
is also Tla” (Table 2), and BIO.M(Tlaa) 
lymphocytes did not absorb all reactivity 
against BlO.S(SR). The possibility of these 
weak reactions being due to an anti-Tla. 1 , 3  
antibody was thus ruled out. Another possi- 
bility was that the recombinant haplotypes 
(t4, i3, i5) carried a chromosomal segment of 
k origin located between the I-B and I-C 
subregions. This hypothesis is compatible 
with the origin of these recombinants from 
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the H-2" haplotype (haplotype composition 
kkkddd) which should then carry the same k 
segment. Moreover, this segment should 
also be present in the H-2Y' haplotype of 
AQR, whose lymphocytes were used for 
immunization in the production by B1O.S 
and BI0.M of the reactivity against 
BIO.S(SR). The  complete absorption 
obtained by increasing the amount of B1O.S 
lymphocytes would have to be due to non- 
specific absorption of a weak antibody. This 
hypothesis would also explain the reactivity 
of both immune sera against BIO.A(SR) and 
BlO.A(5R) lymphocytes (bbbddd) even 
though BIOlSn (bbbbb) and B10.DZ (ddddd) 
are non-reactive as they are due to the same 
k segment derived from H-2". Experiments 
are in progress to test this hypothesis (Sachs 
et al. 1975, David & Shreffler, in prepara- 
tion). 
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